Literature DB >> 21577035

Cancer stem cells: characteristics and their potential role for new therapeutic strategies.

Stephan R Bohl1, Andreas Pircher, Wolfgang Hilbe.   

Abstract

With the cancer stem cell (CSC) hypothesis many questions regarding cancer development and drug resistance can be answered more coherently than with the traditional model based on clonal evolution. CSCs are a small subset of cancer cells within the tumour that show stem cell characteristics like self-renewal, the capability to develop into multiple lineages and the potential to proliferate extensively, and are characterised by a typical profile of different markers like CD44 and CD133. In the CSC model, the role of embryonic pathways like Wnt, Hedgehog and Notch is of special interest. This review presents current scientific knowledge on this topic and discusses the potential role of CSC in the resistance against chemotherapy or radiation and presents challenging options for therapeutic interventions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21577035     DOI: 10.1159/000327815

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  6 in total

1.  Preparation of epithelial and mesenchymal stem cells from murine mammary gland.

Authors:  Ian Guest; Zoran Ilic; Jun Ma
Journal:  Curr Protoc Toxicol       Date:  2011-11

Review 2.  The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.

Authors:  Gaetano Romano
Journal:  Scientifica (Cairo)       Date:  2013-12-05

3.  Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma.

Authors:  Youn Young Park; Chang Hyeok An; Seong Taek Oh; Eun Deock Chang; Jaeim Lee
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes.

Authors:  Moritz Eißmann; Bettina Schwamb; Inga Maria Melzer; Julia Moser; Dagmar Siele; Ulrike Köhl; Ralf Joachim Rieker; David Lukas Wachter; Abbas Agaimy; Esther Herpel; Peter Baumgarten; Michel Mittelbronn; Stefanie Rakel; Donat Kögel; Stefanie Böhm; Tony Gutschner; Sven Diederichs; Martin Zörnig
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

5.  Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.

Authors:  Xuefang Wu; Feng Luo; Jinbang Li; Xueyun Zhong; Kunping Liu
Journal:  Int J Oncol       Date:  2016-01-26       Impact factor: 5.650

6.  Selection and targeting of EpCAM protein by ssDNA aptamer.

Authors:  Walhan Alshaer; Nidaa Ababneh; Mamon Hatmal; Heba Izmirli; Moujab Choukeife; Alaa Shraim; Nour Sharar; Aya Abu-Shiekah; Fadwa Odeh; Abeer Al Bawab; Abdalla Awidi; Said Ismail
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.